8-K: ClearSign Technologies Expands Board, Appoints Two New Directors and Resolves Shareholder Disputes

ClearSign Technologies Corporation announced the expansion of its Board of Directors from five to seven members, appointing Louis J. Basenese and Anthony DiGiandomenico, while resolving prior director nomination disputes with key shareholders.

Summary

• ClearSign Technologies Corporation increased its Board of Directors from five to seven members, effective May 22, 2025.
• Louis J. Basenese and Anthony DiGiandomenico were appointed as new members of the Board.
• Mr. Basenese was determined to be independent under Nasdaq rules and appointed to the Human Capital and Compensation Committee.
• Mr. DiGiandomenico was determined not to be independent by the Special Committee of the Board and was not appointed to any committees.
• David M. Maley, a current director, notified the Company on May 27, 2025, that he will not stand for re-election at the 2025 Annual Meeting; his departure was not due to any disagreement with the Company.
• The Company entered into cooperation agreements with Richard D. Clarkson and Anthony DiGiandomenico, resolving their previous director nomination attempts for the 2025 Annual Meeting.
• These agreements include standstill provisions, mutual non-disparagement clauses, and a general release of claims against ClearSign by the investor parties.
• ClearSign agreed to reimburse Mr. Clarkson up to $2,000 and Mr. DiGiandomenico up to $20,000 for reasonable, well-documented out-of-pocket fees and expenses related to the agreements and in exchange for the general release.
• New directors will receive an award of restricted stock units (RSUs) valued at $15,000 on the first day of every quarter for board service, with Mr. Basenese receiving an additional $750 per quarter for committee service.
• Mr. DiGiandomenico declined to accept the initial pro-rated RSU grant for the quarter ending June 30, 2025.

Sentiment

Score: 7

Explanation: The sentiment is moderately positive. The resolution of shareholder disputes and the addition of experienced directors are beneficial for corporate stability and strategic direction. However, the non-independent status of one new director and the specific clause regarding confidential information sharing, while mitigated by safeguards, introduce minor governance considerations. The amicable departure of a long-serving director also presents a slight negative, though it was amicable.

Positives

• Resolution of potential proxy contest and shareholder activism, leading to a more stable corporate governance environment.
• Addition of two experienced directors, Louis J. Basenese and Anthony DiGiandomenico, who bring expertise in equity research, investment banking, strategic planning, and disruptive technologies.
• Mr. Basenese's independent status and appointment to the Compensation Committee enhance corporate governance and oversight.
• The cooperation agreements include standstill provisions, which limit future disruptive actions by the investor parties until at least the 2026 annual meeting.

Negatives

• Mr. DiGiandomenico was determined not to be an independent director, which could raise questions about overall board independence, despite his exclusion from committees.
• The departure of David M. Maley, who served on three key committees (Audit and Risk, Nominating and Corporate Governance, and Compensation), creates a vacancy and potential loss of institutional knowledge.
• The Company incurred expenses of up to $22,000 for reimbursements to the investor parties as part of the cooperation agreements.
• The provision allowing Mr. DiGiandomenico to share confidential information with investor parties (subject to a confidentiality agreement) introduces a potential governance risk, even with safeguards.

Risks

• Shareholder Activism: While current disputes are resolved, the underlying shareholder activism could resurface after the standstill period concludes (after the 2026 annual meeting or a Change of Control transaction).
• Board Independence: The appointment of a non-independent director (Mr. DiGiandomenico) could potentially impact perceptions of board independence, despite his non-appointment to key committees.
• Confidential Information Disclosure: The agreement allowing Mr. DiGiandomenico to share confidential information with investor parties, even with a confidentiality agreement and trading restrictions, introduces a risk of information leakage or misuse.
• Loss of Expertise: The amicable departure of David M. Maley, who served on critical committees, could result in a loss of specific expertise or continuity, depending on future board appointments.
• Future Board Composition: The Board has not yet determined whether it will reduce its size or nominate a replacement for Mr. Maley, leaving uncertainty regarding future board structure.

Future Outlook

The company anticipates a more stable corporate governance environment following the resolution of shareholder nomination disputes and the addition of new directors. The new directors are expected to contribute their capital markets experience and industry connections to the Board. The Board will determine whether to reduce its size or nominate a replacement for the departing director at a later time.

Management Comments

• "I am very pleased to welcome both Anthony and Lou to the Board. Both have been long time supporters of ClearSign. Their existing knowledge of the Company and its technologies combined with their capital markets experience and industry connections will make them valuable and productive additions to the Board." Jim Deller, Ph.D., Chief Executive Officer of ClearSign.
• "Additionally, David Maley has indicated that he will not be standing for re-election on the upcoming annual meeting of stockholders, and we thank him for his service to ClearSign." Jim Deller, Ph.D., Chief Executive Officer of ClearSign.

Industry Context

This announcement reflects a common trend in corporate governance where companies engage with activist shareholders to resolve disputes and enhance board composition. The addition of directors with capital markets and technology experience aligns with the strategic needs of companies in the industrial combustion and sensing technologies sector, particularly those focused on decarbonization and energy efficiency, which often require strong investor relations and strategic guidance for growth.

Comparison to Industry Standards

• The appointment of directors with extensive experience in equity research, investment banking, and disruptive technologies (e.g., Mr. Basenese from Prairie Operating Co. and ENDRA Life Sciences, Inc.; Mr. DiGiandomenico from MDB Capital Holdings, LLC, Provention Bio, Inc., and Cue Biopharma, Inc.) aligns with industry best practices for enhancing board expertise, particularly for a company in an emerging technology sector like industrial combustion and sensing.
• The resolution of shareholder nomination disputes through cooperation agreements, including standstill provisions and mutual non-disparagement, is a standard approach to mitigate the costs and distractions of proxy contests, similar to agreements seen with other publicly traded companies facing activist pressure.
• The compensation structure for non-management directors, involving restricted stock units, is a common practice designed to align director incentives with long-term shareholder value.
• The determination of Mr. DiGiandomenico as non-independent, while Mr. Basenese is independent, reflects adherence to Nasdaq listing rules regarding director independence, which is a key corporate governance standard.

Management Changes

Corporate Governance

Legal Proceedings

• The cooperation agreements include a general release of claims by the investor parties against ClearSign, subject to limited exceptions (e.g., claims to enforce the agreement, and for Mr. DiGiandomenico, rights under specific underwriting and offering agreements from April 2024 and February 2018). This indicates a resolution of potential or existing disputes.
• The agreements also include mutual non-litigation clauses during the standstill period, except for enforcing the agreements themselves.

Related Party Transactions

• Anthony DiGiandomenico is the Chief of Transactions and a director of MDB Capital Holdings, LLC, which he co-founded. Louis J. Basenese also previously served as President and Chief Market Strategist of MDB Capital Holdings, LLC.
• The cooperation agreements involve payments from ClearSign to Mr. Clarkson (up to $2,000) and Mr. DiGiandomenico (up to $20,000) for expenses and in exchange for a general release of claims.
• The provision allowing Mr. DiGiandomenico to share confidential information with investor parties (subject to a confidentiality agreement) could be considered a related party arrangement due to his role as a 'stockholder designee'.

Stakeholder Impact

• Shareholders: The resolution of director nomination disputes and the implementation of standstill agreements are likely to be viewed positively, reducing uncertainty and potential proxy fight costs. The addition of experienced directors could enhance strategic oversight. The expense reimbursements to the investor parties are a minor cost. The provision for confidential information sharing with investor parties (via Mr. DiGiandomenico) could be seen as increasing transparency for certain large shareholders, but also raises potential concerns about information asymmetry if not managed carefully.
• Board of Directors: The board size increases, and new members bring diverse experience. The departure of a long-serving director necessitates future decisions on board composition.
• Management: A more stable board and reduced activist pressure allow management to focus on core business operations and strategic execution.

Next Steps

• The Board will nominate Louis J. Basenese and Anthony DiGiandomenico for election at the 2025 Annual Meeting.
• The Board will determine whether to reduce its size or nominate a replacement director for David M. Maley.
• The cooperation agreements will remain in effect until the earlier of the conclusion of ClearSign's 2026 annual meeting of stockholders or a Change of Control transaction.
• Any confidential information shared by Mr. DiGiandomenico with investor parties will require a customary confidentiality agreement.

Key Dates

Recommendation

Keywords

ClearSign Technologies, CLIR, Board of Directors, Corporate Governance, SEC Filing, 8-K, Director Appointment, Shareholder Activism, Cooperation Agreement, Restricted Stock Units, Nasdaq, Louis J. Basenese, Anthony DiGiandomenico, David M. Maley, Executive Compensation, Risk Management, Investor Relations